Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury

Role of purinergic signalling in neuro-immune cells and adult neural progenitors

(2011) Marta Fumagalli   Frontiers in Bioscience-Landmark

The GPR17 receptor in NG2 expressing cells: Focus on in vivocell maturation and participation in acute trauma and chronic damage

(2011) Enrica Boda et al.   GLIA

Progenitors in the adult cerebral cortex: Cell cycle properties and regulation by physiological stimuli and injury

(2011) Christiane Simon et al.   GLIA

Phenotypic Changes, Signaling Pathway, and Functional Correlates of GPR17-expressing Neural Precursor Cells during Oligodendrocyte Differentiation

(2011) Marta Fumagalli et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases

(2011) Ivano Eberini et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Agonist-Induced Desensitization/Resensitization of Human G Protein-Coupled Receptor 17: A Functional Cross-Talk between Purinergic and Cysteinyl-Leukotriene Ligands

(2011) S. Daniele et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Generation of subtype-specific neurons from postnatal astroglia of the mouse cerebral cortex

(2011) Christophe Heinrich et al.   Nature Protocols

NG2-glia as Multipotent Neural Stem Cells: Fact or Fantasy?

(2011) William D. Richardson et al.   NEURON

International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions

(2011) M. Back et al.   PHARMACOLOGICAL REVIEWS

Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17

(2011) Michela Buccioni et al.   Purinergic Signalling

Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT2) receptor

(2010) F Wunder et al.   BRITISH JOURNAL OF PHARMACOLOGY

Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants

(2010) T Benned-Jensen et al.   BRITISH JOURNAL OF PHARMACOLOGY

Regulation of PC12 cell survival and differentiation by the new P2Y-like receptor GPR17

(2010) Simona Daniele et al.   CELLULAR SIGNALLING

Excitability and Synaptic Communication within the Oligodendrocyte Lineage

(2010) L. M. De Biase et al.   JOURNAL OF NEUROSCIENCE

Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPγS binding and electrophysiological studies in 1321N1 cells

(2009) Anna Maria Pugliese et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury

(2009) Stefania Ceruti et al.   BRAIN

GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4

(2009) Akiko Maekawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Uracil nucleotides: From metabolic intermediates to neuroprotection and neuroinflammation

(2008) Davide Lecca et al.   BIOCHEMICAL PHARMACOLOGY

A new penumbra: transitioning from injury into repair after stroke

(2008) Eng H Lo   NATURE MEDICINE

The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain Repair

(2008) Davide Lecca et al.   PLoS One

Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain

(2008) A. Buffo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA